Aperam S.A.

APEMY · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Revenue$6,255,000$6,592,000$8,156,000$5,102,000
% Growth-5.1%-19.2%59.9%
Cost of Goods Sold$5,806,000$6,262,000$6,976,000$3,869,000
Gross Profit$449,000$330,000$1,180,000$1,233,000
% Margin7.2%5%14.5%24.2%
R&D Expenses$0$24,000$21,000$18,000
G&A Expenses$104,000$97,000$88,000$191,000
SG&A Expenses$117,000$109,000$108,000$191,000
Sales & Mktg Exp.$13,000$12,000$20,000$0
Other Operating Expenses$203,000-$60,000$0$0
Operating Expenses$320,000$241,000$290,000$191,000
Operating Income$129,000$89,000$890,000$1,042,000
% Margin2.1%1.4%10.9%20.4%
Other Income/Exp. Net-$51,000$28,000-$138,000$1,000
Pre-Tax Income$78,000$117,000$752,000$1,043,000
Tax Expense-$154,000-$87,000$126,000$74,000
Net Income$231,000$203,000$625,000$968,000
% Margin3.7%3.1%7.7%19%
EPS3.22.798.3312.22
% Growth14.7%-66.5%-31.8%
EPS Diluted3.172.798.2912.17
Weighted Avg Shares Out72,27072,76075,06279,241
Weighted Avg Shares Out Dil72,80872,77675,40379,557
Supplemental Information
Interest Income$19,000$10,000$22,000$6,000
Interest Expense$47,000$43,000$22,000$10,000
Depreciation & Amortization$229,000$204,000$184,000$146,000
EBITDA$354,000$364,000$958,000$1,197,000
% Margin5.7%5.5%11.7%23.5%